TACO time - Trump says Putin doesn’t have to agree to meet with Zelenskiy to meet with me

EA's 27.6% FCF margin & 35.3% EBITDA beat; ISRG's 18.9% revenue growth & 21.4% EPS growth; AR's slowing growth & falling EBITDA margin.

Inflation hits 3.3%! WMT & KO offer stability. KO's 2.7% yield, WMT's premium valuation hedge against rising costs.

DE & NOVT face headwinds: declining sales & margins. APH shines with 35% revenue growth & strong FCF.

APP surges on 29.2% revenue growth, 16x P/S. PAY boasts 39.5% revenue growth, 32.7x P/E. PII faces flat sales, low returns.

GS beats Q1 revenue & EPS! TBVPS up 10.5% YoY, but trading misses. Shares dip 3.6%.

RevMed's cancer drug shows unprecedented survival rates, nearly doubling outcomes in trials. High hopes for valuation.

HIG's 6.5% growth & 1.9x P/B raise caution; ADM's sales tank 7.5% & EPS dips 24.2%. ELV shines with 10.3% sales growth & 12.2x P/E.